NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 59 filers reported holding NIVALIS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $8,995,000 | -17.5% | 3,732,412 | 0.0% | 0.48% | +14.3% |
| Q1 2017 | $10,899,000 | +30.4% | 3,732,412 | 0.0% | 0.42% | +22.1% |
| Q4 2016 | $8,361,000 | -72.4% | 3,732,412 | 0.0% | 0.34% | -75.6% |
| Q3 2016 | $30,345,000 | +76.7% | 3,732,412 | 0.0% | 1.41% | +109.0% |
| Q2 2016 | $17,169,000 | +10.3% | 3,732,412 | 0.0% | 0.68% | +1.8% |
| Q1 2016 | $15,564,000 | -46.1% | 3,732,412 | 0.0% | 0.66% | -43.4% |
| Q4 2015 | $28,889,000 | -40.3% | 3,732,412 | 0.0% | 1.17% | -37.5% |
| Q3 2015 | $48,409,000 | -14.4% | 3,732,412 | 0.0% | 1.87% | -0.6% |
| Q2 2015 | $56,546,000 | – | 3,732,412 | – | 1.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|